Aperiomics is a biotech company providing healthcare and revolutionizing infection testing. The company identifies every bacterium, virus, fungus, and parasite known to modern science through its Deep Shotgun Metagenomic Sequencing process. Its Xplore-PATHOSM Test combined advanced DNA testing, big data, and infectious disease expertise to identify the root cause of infectious diseases.
Type | Private | |
Founded | 2013 | |
HQ | Sterling, VA, US | Map |
Website | aperiomics.com | |
Overall Culture | A+ | More |
Employees (est.) (Jan 2021) | 19 | (+6%) |
Cybersecurity rating | B | More |
Founding Date | 2013 |
Aperiomics total Funding | $2.3 m |
Aperiomics latest funding size | $1.80 m |
Time since last funding | a year ago |
Aperiomics investors | Pipeline Angels, VentureSouth, Propel(x) |
Aperiomics has 1.83k Twitter Followers. The number of followers has decreased 1.6% month over month and decreased 2% quarter over quarter
A+
97/100
A+
100/100
A+
100/100
When was Aperiomics founded?
Aperiomics was founded in 2013.
Who are Aperiomics key executives?
Aperiomics's key executives are Yuan Chen, C. Alexander Valencia and Elizabeth P Pyle.
How many employees does Aperiomics have?
Aperiomics has 19 employees.
Who are Aperiomics competitors?
Competitors of Aperiomics include BAG Diagnostics, Fitgenes and 3billion.
Where is Aperiomics headquarters?
Aperiomics headquarters is located at 45925 Horseshoe Dr STE 170, Sterling.
Where are Aperiomics offices?
Aperiomics has an office in Sterling.
How many offices does Aperiomics have?
Aperiomics has 1 office.
Receive alerts for 300+ data fields across thousands of companies